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ABSTRACT
Ribonuclease H2 is the major nuclear enzyme
degrading cellular RNA/DNA hybrids in eukaryotes
and the sole nuclease known to be able to hydrolyze
ribonucleotides misincorporated during genomic
replication. Mutation in RNASEH2 causes Aicardi–
Goutie`res syndrome, an auto-inflammatory disorder
that may arise from nucleic acid byproducts
generated during DNA replication. Here, we report
the crystal structures of Archaeoglobus fulgidus
RNase HII in complex with PCNA, and human PCNA
bound to a C-terminal peptide of RNASEH2B. In
the archaeal structure, three binding modes are
observed as the enzyme rotates about a flexible
hinge while anchored to PCNA by its PIP-box motif.
PCNAbinding promotesRNaseHII activity in a hinge-
dependent manner. It enhances both cleavage of
ribonucleotides misincorporated in DNA duplexes,
and the comprehensive hydrolysis of RNA primers
formed during Okazaki fragment maturation. In
addition, PCNA imposes strand specificity on
enzyme function, and by localizing RNase H2 and
not RNase H1 to nuclear replication foci in vivo it
ensures that RNase H2 is the dominant RNase H
activity during nuclear replication. Our findings
provide insights into how type 2 RNase H activity
is directed during genome replication and repair,
and suggest a mechanism by which RNase H2 may
suppress generation of immunostimulatory nucleic
acids.
INTRODUCTION
RNA/DNA hybrids form during many key cellular
processes including DNA replication (1), transcription
(2) and telomere elongation (3). Ribonuclease H (RNase
H) endonucleases degrade the RNA strand of such RNA/
DNA hybrids and therefore have a central importance in
cellular physiology.
Eukaryotes have two classes of cellular RNase H
enzymes: type 1 and 2 (4). RNase H1 (a type 1 enzyme)
is essential for mitochondrial replication (5), while RNase
H2 (a type 2 enzyme) is the predominant source of RNase
H activity in mammalian cells (6). Despite low sequence
similarity, both enzymes cleave at the 50-end of RNA
phosphodiester bonds using a highly conserved two
metal ion catalytic mechanism (7–9). In addition, RNase
H2 has the apparently unique ability to hydrolyze the
50-phosphodiester bond of single ribonucleotides
embedded in a DNA duplex (10,11).
Partial loss-of-function mutations in RNase H2 are a
common cause of Aicardi–Goutie`res syndrome (AGS)
(12,13). AGS is an auto-inﬂammatory genetic disorder
that mimics in utero viral infection (14) and has immuno-
logical similarities to the autoimmune disease systemic
lupus erythematosis (12,15). Inﬂammation is thought to
be triggered by accumulating nucleic acid substrates that
are normally degraded by cellular nucleases (16). Studies
on TREX1, another nuclease mutated in AGS, have sug-
gested that such nucleic acids may arise from recently
replicated DNA (17), highlighting the need to understand
the role of AGS nucleases in DNA replication.
During genomic DNA replication, synthesis on the
lagging strand occurs discontinuously as Okazaki
fragments. Synthesis is initiated by short RNA primers,
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on an average of 10 nt in length (18). During Okazaki
fragment maturation these RNA primers are removed
prior to fragment joining to form a continuous lagging
strand. Several pathways for primer removal exist (19),
and in vitro biochemical studies indicate that the sequential
activities of RNase H2 and FEN1may be involved (20–22).
Additionally, as RNase H2 recognizes single ribonucleo-
tides embedded in a DNA duplex, it is likely to have a
role in DNA repair, facilitating removal of RNA bases
misincorporated during genomic DNA replication (23).
Recently, replicative DNA polymerases have been found
to incorporate signiﬁcant numbers of ribonucleotides
during DNA synthesis (24), and so a role for RNase H2
in their removal may well be crucial to maintain genomic
stability.
RNase H2 has been reported to interact with prolife-
rating cell nuclear antigen (PCNA), although the
functional consequences of this interaction were not estab-
lished (25,26). PCNA assembles into a trimeric toroid (27)
that clamps around double-stranded DNA. It acts both as
a scaffold and catalyst for DNA-editing enzymes during
DNA replication and repair (28). Many PCNA-interacting
proteins bind a common hydrophobic groove near the
PCNA C-terminus via a conserved peptide motif termed
the PCNA interacting peptide (PIP) box motif (29,30).
The PIP-box is deﬁned by the sequence Qxxmxx
where x is any residue, m is aliphatic hydrophobic and 
is an aromatic.
Archaeoglobus fulgidus (Afu) RNase HII is a single
protein containing both the PIP-box (residues 199–205;
QKTLDDF) and catalytic center, while the eukaryotic
RNase H2 is a heterotrimeric complex with all three
protein subunits required for enzymatic activity (11). The
RNASEH2A subunit of the human enzyme contains the
active site and forms a complex with the intimately
interwoven RNASEH2B and RNASEH2C subunits (31).
RNASEH2B possesses the PIP-box (residues 294–301;
MKSIDTFF) which mediates its interaction with PCNA
(26). The functional signiﬁcance of this interaction between
PCNA and type 2 RNase H is unclear as an inhibitory
effect of PCNA on RNase HII enzymatic activity was
seen in the thermophilic archaeon Pyrococcus abyssi (25)
and no difference in human RNase H2 activity was
observed in the presence of PCNA (26).
Given the potential roles of RNase H2 in genome
replication and repair, and its relevance to autoimmune
disease, we investigated the biological signiﬁcance of the
interaction between PCNA and type 2 RNase H. Here, we
report the crystal structures of the Afu PCNA:RNase HII
complex, as well as that of human PCNA bound to a
peptide from human RNASEH2B. We establish the func-
tional relevance of this interaction, demonstrating
enhancement of RNase HII activity by PCNA both on
ribonucleotides embedded within DNA and on Okazaki-
like fragments. We also ﬁnd that PCNA confers strand
speciﬁcity to the enzyme’s action. Finally, we demonstrate
that RNase H2 is the only RNase H enzyme to localize to
replication foci in mammalian cells through its interaction
with PCNA, and suggest how it may suppress generation
of inﬂammatory self nucleic acids.
MATERIALS AND METHODS
Cloning, expression and puriﬁcation
Archaeoglobus fulgidus RNase HII and derivatives were
expressed in Rossetta-2 using pGEX6P1-based vectors.
Deletions and point mutations were introduced using the
Quikchange method (Stratagene). Archaeoglobus fulgidus
PCNA and human PCNA expression constructs were kind
gifts from Professor J. Tainer (Scripps Research Institute)
and Dr L. Cox (University of Oxford), respectively. For
ﬂuorescence microscopy RNASEH2B and RNASEH2C
were cloned into pEGFP-C2-Dest, RNASEH1 into
pEGFP-N1. For details see Supplementary Table S1.
Cells were grown to OD600 0.6 at 37
C and expression
was induced with 1mM IPTG for 3 h. Cells were pelleted
and lysed by sonication in a PBS buffer containing
0.2% Tween, 10mM MgCl2, Protease Inhibitor Cocktail
(Sigma; 50ml per gram of cell pellet) and 100mg DNase I
and 100 mg RNase A (Sigma; amounts per gram of cell
pellet). GST-tagged proteins were bound to glutathione
sepharose 4B beads, released by cleavage with PreScission
protease (GEHealthcare Life Sciences) and further puriﬁed
by size-exclusion chromatography in 150mM NaCl,
20mM Tris pH 7. Human and Afu PCNA were puriﬁed
as previously described (27,32). Archaeoglobus fulgidus
PCNA:RNase HII complex was separated from individual
components by size-exclusion chromatography using a
Superdex 200 column (GE Healthcare Life Science).
Crystallization, data collection and reﬁnement
Crystals were grown by vapor diffusion at room tempera-
ture in 96-well plates with 0.2 ml drops. Equal volumes
of pre-formed Afu PCNA:RNase HII complex (10mg/ml
in 150mM NaCl, 20mM Tris pH7) and precipitant
(18% w/v PEG3350, 196mM K2HPO4 pH 9.2) were
mixed. Crystals were cryoprotected with reservoir
solution and 20% glycerol before cryocooling at 100K.
Diffraction data were collected at a wavelength of 1.00 A˚
at Diamond Light Source (Oxford, UK) at I04.
A peptide consisting of residues 290–312 from the
RNASEH2B C-terminus (DKSGMKSIDTFFGVKNK
KKIGKV; PIP-box motif underlined) was synthesized
by solid phase synthesis, puriﬁed to >95% by reverse
phase HPLC and freeze dried (Alta Bioscience). It was
then rehydrated in 150mM NaCl, 20mM Tris pH7 and
mixed with human PCNA (20mg/ml) in equimolar
amounts. Crystals grew in 3M NaCl, 0.1M citrate pH
3.5 and were dipped in perﬂuoropolyether PFO-X125/03
(Lancester Synthesis) before cryocooling. Diffraction data
were collected at a wavelength of 0.982 A˚ at Diamond
Light Source (Oxford, UK) at I03.
Data sets were integrated and scaled using HKL2000
(33) or CCP4/MOSFLM (34) scripted by Xia2 (35).
Structures were determined by molecular replacement
using Phaser (36) with Afu RNase HII (PDB ID: 1I39;
residues 1–189) and Afu PCNA (PDB ID: 1RXM), or
human PCNA (PDB ID: 1AXC) as search models.
Models for the Afu RNase HII hinge and PIP-box and
human RNASEH2B peptide were manually built using
COOT (37). Models were initially reﬁned with Phenix
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(38) followed by further cycles with BUSTER-TNT (39)
implementing 3-fold NCS restraints and TLS. Non-
crystallographic local structure similarity restraints (40)
were also used to deter deviation of the models from the
target high-resolution apo RNase HII and PCNA crystal
structures, unless evidence for a difference was present in
the electron density. The geometry of the ﬁnal reﬁnement
for both structures was assessed using MOLPROBITY
(41). Of the residues in the Afu PCNA:RNase HII
complex, 98.1% were in the favored region of the
Ramachandran plot; none in the disallowed region. For
the PCNA:peptide complex, 97.2% were in the favored
region and 0.1%were outliers. All superpositions for struc-
tural analysis were done by secondary structure matching
in COOT, unless otherwise indicated.
Modelling interaction with substrate
An RNA/DNA hybrid was modeled into the
PCNA:RNase HII complex as previously described for
murine RNase H2 (31). The RNA/DNA hybrid from
the Escherichia coli RNase HI co-crystal structure (PDB
ID: 1ZBI) was docked into the active site of Afu RNase
HII based on the conserved metal coordination geometry
between the two enzymes. As the E. coli structure was
obtained using an RNase HI active site mutant
(D132N), the positions of the furthest side chain carbon
atoms were used as a proxy for the two oxygen atoms per
active site residue that chelate the metal ions (E. coli
RNase HI: CgD71, CgN132, CgD192; CdE109; Afu
RNase HII: CgD6, CgD101, CgD129; CdE7). A
least-squares ﬁt of atoms from E. coli RNase HI on
those from the three Afu RNase HII conformations was
carried out using LSQ Superpose in COOT (37), inde-
pendent of residue identity. The rotation and translation
matrix generated was applied to the RNA/DNA hybrid
(PDB ID: 1ZBI, chains A and B) using PDBSET in the
CCP4 package (34). B-form DNA duplexes were
generated in COOT and manually docked to continue
the helix from the 50-end of the hybrid through the
PCNA ring. The hybrid and DNA duplex were joined
after 10 cycles of idealization in REFMAC (42).
Co-precipitation experiments
Glutathione sepharose 4B beads with bound GST-RNase
HII (1 mg) were mixed with non-tagged PCNA (0.4 mg) in
NETN buffer (20mM Tris pH 8, 100mM NaCl, 1mM
EDTA, 0.5% NP-40) and incubated for 30min at 4C.
Unbound proteins were collected and beads washed with
buffer. Bound and unbound proteins were separated by
SDS-PAGE (12%) and visualized with Coomassie stain.
To test for interactions of EGFP-RNASEH2B, transi-
ently transfected COS7 cells were cross-linked for 30min
at 37C with 0.25% formaldehyde, and cell lysates
prepared as previously described (43). Proteins were
captured with GFP-Trap beads as instructed by the manu-
facturer (Chromotek). Bound and unbound proteins were
separated by SDS-PAGE and visualized by Western
analysis using antibodies against GFP (JL8), PCNA
(PC10), RNASEH2A and RNASEH2C.
RNase H activity assays
Ribonucleotide-containing oligonucleotides (32P end-
labeled) were annealed to unlabeled complementary
DNA oligonucleotides (Supplementary Table S2 by
heating for 5min at 95C and slow cooling to room
temperature in 60mM KCl, 50mM Tris–HCl pH 8.
Substrates and proteins were diluted in RNase H2
reaction buffer (50mM Tris–HCl pH8, 60mM KCl,
10mM MgCl2, 0.01% BSA and 0.01% Triton).
Although the optimal growth temperature for A. fulgidus
is 83C, in keeping with previous studies (7,25), reactions
were performed at 30C. Reactions (5 ml) were incubated
at 30C for 20min, unless otherwise indicated, and
stopped by the addition of formamide loading dye.
Samples were separated on 20% polyacrylamide (19:1,
1 TBE, 8M urea) gels and bands were visualized by
autoradiography.
Steady state enzyme kinetics
Experiments were performed using the conditions
described by Chapados et al. (7) in the ﬂuorescence-based
enzyme assay described by Crow et al. (12) with 1 nM
RNase HII and 1 mM PCNA at substrate concentrations
ranging from 0 to 5 mM. Kinetic parameters Km and Vmax
were determined using non-linear regression in SigmaPlot
11.0 (Systat Software Inc.).
Fluorescence microscopy
Transiently tranfected COS7 cells were ﬁxed in 4% for-
maldehyde in PBS. Alternatively, cells were detergent
extracted with 0.5% Triton X-100 in PBS for 5min at
room temperature, before ﬁxing in 70% methanol-30%
acetone (v/v) for 15min at 20C. For immunostaining,
cells were blocked in 1% (v/v) fetal calf serum (FCS) in
PBS, incubated with anti-PCNA antibody (PC10; Santa
Cruz), washed in 1% FCS-PBS and incubated with sec-
ondary antibody (Alexa ﬂuor 568; Invitrogen). Imaging
was performed using a Coolsnap HQ CCD camera
(Photometrics) and a Zeiss Axioplan II ﬂuorescence
microscope with Plan-neoﬂuar objectives.
RESULTS
Crystal structure of the PCNA:RNase HII complex
from A. fulgidus
The crystal structure of the Afu PCNA:RNase HII
complex was solved by molecular replacement to 3A˚ reso-
lution (Table 1). Three RNase HII molecules (23 kDa)
bind the physiological PCNA homotrimer (81 kDa)
(Figure 1 and Supplementary Figure S1). The primary
interface is formed by the PIP-box motif of RNase HII
that binds a hydrophobic groove proximal to the PCNA
C-terminus. RNase HII rotates about a ﬂexible hinge re-
sulting in three distinct binding modes: two RNase HII
molecules extend away from the ring, while the third
occludes the central PCNA channel (Figure 1). Although
portions of the RNase HII molecules are involved in
crystal contacts, an analysis of the buried surface area
using PISA (44) indicated that the contribution of
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interfaces within the asymmetric unit (PCNA to RNase
HII, PCNA to PCNA and RNase HII to RNase HII)
are larger than of crystallographic contacts.
The Afu PCNA trimer in our crystal structure forms a
closed ring with pseudo 6-fold symmetry. The core
b-sheets comprise the outer circle while a-helices line the
center of a toroid whose inner surface charge is comple-
mentary to a DNA duplex. This assembly is representative
of the architecture observed for other PCNAs, irrespective
of species and binding partner (27,45,46).
The previously reported structure of apo Afu RNase
HII (7) revealed the protein to have an N-terminal
globular domain (residues 1–157), consisting of a b-sheet
ﬂanked by a-helices, and a C-terminal helical cap (residues
158–200). In the active site, four catalytic residues (D6,
E7, D101 and D129) chelate two metal ions. The core
features of the unbound structure are preserved upon
complex formation. Speciﬁcally, PCNA binding does not
perturb the a/b fold of the N-terminal domain and the
active site chemistry is conserved (Figure 2A). In the
complex, the helical cap of RNase HII undergoes a
conformational change, and as a result the extreme
C-terminus becomes ordered, adopting a structure
similar to that of the FEN1 C-terminus when bound to
PCNA (45). Although it lacks the second aromatic residue
of the consensus motif, the Afu RNase HII PIP-box still
forms the 310 helix that locks into the hydrophobic groove
proximal to the PCNA C-terminus.
A ﬂexible hinge region (residues 195–198) links the
core of RNase HII with its PIP-box (residues 199–205)
(Figure 2A). This hinge enables a wide range of motion
of RNase HII relative to PCNA, three states of which are
captured in the crystal structure. In the two extended con-
formations, the hinge is well ordered and makes additional
contacts with PCNA (Figure 1A, B, C and F); while in the
third conformation it is less ordered (Figure 1D). Notably,
hinge residue RNase HII:R198, which immediately
precedes the PIP-box, adopts a different conformation in
each binding mode. In one heterodimer (Figure 1B) its
side chain is extended, stabilizing the last residue of
PCNA (S244). In addition, the guanidinium group
of PCNA:R241 hydrogen bonds with the hydroxyl of
RNase HII hinge residue S195. In the second heterodimer
(Figure 1C), the side chain of RNase HII:R198 is folded
back, disrupting the interaction between RNase HII:S195
and PCNA:R241. Consequently, PCNA:R241 forms a salt
bridge with PCNA:D150. Signiﬁcantly, the hinge could
serve as a molecular switch to facilitate the transition
between different binding modes of RNase HII.
We analyzed the range of motion between RNase HII
and PCNA (Figure 1 and Supplementary Movie S1).
Two of the three RNase HII molecules differ by only a
9 rotation, and their active sites lie at similar distances
(46 A˚ and 49 A˚, respectively) above the center of the ring
(Figure 1B, C and E). The orientation of the third RNase
HII molecule is remarkably different from the other two.
Here, the core RNase HII domain is rotated a further 45,
capping one face of the ring and bringing the active site
within 19 A˚ of the ring center (Figure 1D and E). In this
binding mode, the N-terminal core domain of RNase HII
makes additional contacts with a second PCNA monomer
and substantially occludes the central channel. Given the
more extensive interface and obstruction of the PCNA
ring, this latter state may reﬂect an enzymatically
inactive complex.
PCNA stimulates Afu RNase HII activity on
physiologically relevant substrates
To assess the functional relevance of the interaction
between Afu PCNA and RNase HII we examined the
effect of PCNA on RNase HII activity in vitro. PCNA
was found to stimulate the cleavage of a DNA duplex
with a single embedded ribonucleotide (Figure 2C and
D; data not shown). The speciﬁc activity for cleavage of
D14R1D3:D18 (250 nM) was 13-fold higher (13±3; n=4)
in the presence of PCNA compared to RNase HII alone.
This stimulation was dependent on the interaction of
PCNA with RNase HII, as deletion of the RNase HII
PIP-box abolished PCNA binding and enhancement of
activity (Figure 2B and E). In contrast, deletion of the
hinge region (SNLR) permitted PCNA:RNase HII
complex formation while still resulting in loss of PCNA
stimulation (Figure 2B and F). Taken together, our data
suggest that the hinge that permits the swinging movement
of the RNase HII catalytic domain, is required for enzym-
atic action on substrates threaded through the PCNA
ring.
Given the previous report of inhibition of archaeal
RNase HII by PCNA (25), we next examined whether
the effect of PCNA on RNase HII activity was position
Table 1. Data collection and reﬁnement statistics
Afu
PCNA:RNase
HII
Human
PCNA:RNASEH2B
PIP
Data collection
Space group P21212 P21
Cell dimensions
a, b, c (A˚) 149.7, 152.0, 90.2 83.1, 81.8, 116.6
a, b, g () 90.0, 90.0, 90.0 90.0, 91.5, 90.0
Resolution (A˚) 67.7–3.1 (3.13–3.05)a 47.5–3.0 (3.09–2.99)
Rmerge 0.116 (1.086) 0.126 (0.852)
I/sI 15.8 (2.0) 8.0 (1.8)
Completeness (%) 99.6 (96.6) 99.9 (99.9)
Redundancy 7.3 (7.2) 3.7 (3.8)
Reﬁnement
Resolution (A˚) 67.7–3.1 (3.13–3.05) 47.5–3.0 (3.09–2.99)
No. of reﬂections 39 801 (2819) 31 807 (2930)
Rxpct
b/Rfree
c 18.7 (25.8)/21.6 (30.4) 22.3 (25.9)/24.8 (28.3)
No. of atoms
Protein 10 465 11 486
B-factors (A˚2)
Protein 77.5 72.2
R.m.s. deviations
Bond lengths (A˚) 0.009 0.009
Bond angles () 1.08 1.09
aValues in parentheses are for highest-resolution shell.
bRxpct=100 (hkl ||Fobs| |Fxpct||/hkl |Fobs|), where |Fobs| and
|Fxpct| are the observed structure facture amplitude and the expectation
of the model structure factor amplitude, respectively (39).
cRfree was calculated from a randomly selected subset of the data, cor-
responding to 5%.
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Figure 1. Structure of the Afu PCNA:RNase HII complex. (A) Three RNase HII molecules (cyan, tan and red) bind the PCNA homotrimeric ring
(grey) in unique orientations. Two binding modes (cyan and tan) extend away from the center of the ring, while the third (red) obstructs the opening.
On the right the complex is rotated 90 about the plane of the PCNA ring. (B–D) The three orientations of RNase HII observed in the complex with
PCNA are shown independently from the same viewpoint. Active site residues (D6, E7, D101 and D129) are shown as yellow sticks. RNase HII is
anchored to PCNA by its C-terminal PIP-box motif (residues 199–205) and rotates about a ﬂexible hinge (black arrow). For each binding mode, a
close-up of the hinge region (residues 195–198) reveals conformational changes in RNase HII and PCNA (right panel). PCNA residues R241, S244
(continued)
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dependent. Enzymatic cleavage was assessed using sub-
strates with a single ribonucleotide in different positions
in the same 18 bp DNA duplex. Addition of PCNA had
a stimulatory effect on cleavage when the RNA base was
12, 13, 14, 15 or 16 nt from the 50-end of the substrate,
(Figure 2D and Supplementary Figure S2F–H). In
contrast, increasing the concentration of PCNA had a
weak inhibitory effect when the RNA base was at pos-
itions 4, 6, 8 or 10 (Figure 2G and Supplementary
Figure S2A–E). Afu RNase HII did not cleave at positions
<4 bases from the 50-end or <2 bases from the 30-end,
irrespective of the presence of PCNA (Supplementary
Figure S2A and H and data not shown). A similar
pattern was observed with longer substrates, with PCNA
only stimulating cleavage at positions 30 of base 10
(Supplementary Figure S2I–N). We therefore conclude
that PCNA generally enhances enzymatic activity
against single ribonucleotides embedded within a DNA
duplex, unless the ribonucleotide is within the ﬁrst ten
50-bases of the strand containing it. This is consistent
with the ﬁndings of Meslet-Cladie`re et al. (25) whose sub-
strate contained a single ribonucleotide at position 8.
To establish whether these ﬁndings could be generalized
for other type 2 RNase H substrates, we investigated en-
zymatic activity of PCNA:RNase HII on RNA/DNA
heteroduplexes. A wide distribution of cleavage sites by
RNase HII was observed and addition of PCNA
enhanced cleavage (Supplementary Figure S3). PCNA
also changed the cleavage pattern, inhibiting shorter
cleavage products and shifting the preferred cleavage sites
to generate fragments >12 nt in length. This is consistent
with inhibition of cleavage for the ﬁrst 10 nt. PCNA
appears to enhance enzymatic activity by increasing ef-
fective substrate afﬁnity, as stimulation was not observed
at higher substrate concentration (Supplementary
Figure S3B). Indeed, we show that substrate binding
afﬁnity is signiﬁcantly higher in the presence of PCNA
for both DNA duplex with a single embedded
ribonucleotide and RNA/DNA heteroduplex substrate
(Table 2).
To simulate unprocessed Okazaki fragments in vitro, we
generated the substrate D17+R10D13:D40, which contains
two oligonucleotides, D17 and R10D13 (mimicking the 5
0-
and 30-ends of Okazaki fragments respectively) annealed
to a 40 nt DNA strand (Figure 3A). Another substrate,
R10D13:D40, analogous to Primase-primed DNA, was
generated in which only R10D13 was annealed to the
40 nt reverse strand. RNase HII alone preferentially
cleaved at the phosphodiester bond 50 of the junctional
ribonucleotide, as previously described (47). In contrast,
we observed more frequent cleavage at sites further away
from the junction for substrate D17+R10D13:D40
compared with R10D13:D40 (Figure 3B), suggesting that
the presence of an upstream Okazaki fragment promotes
more extensive hydrolysis of the RNA primer. We
observed the same for human RNase H2
(Supplementary Figure S4). No cleavage of the single
stranded R10D13 was observed for type 2 RNase H (Afu:
Figure 3B; human: Supplementary Figure S4), indicating
that the recombinant enzyme does not act as a junction
ribonuclease on single stranded substrate, contrary to a
previous report (47).
PCNA further enhanced cleavage of D17+R10D13:D40
(Figure 3D and F), whereas it had no or very limited effect
on the hydrolysis of R10D13:D40 that lacks the upstream 3
0
Okazaki fragment (Figure 3C and E). This implies that the
PCNA: RNase HII complex speciﬁcally enhances RNA
primer degradation when synthesis of the upstream
Okazaki fragment has been completed.
Additionally, PCNA:RNase HII appeared to generate
smaller cleavage products with 50-labeled substrate
(Figure 3D). In contrast, PCNA enhanced cleavage of
30-labeled substrate (Figure 3F) at the junctional ribo-
nucleotide, without a signiﬁcant change in the cleavage
pattern. This is consistent with PCNA:RNase HII
promoting increased catalysis at multiple sites rather
than altering cleavage site preference, and could reﬂect
increased RNase HII processivity when bound to PCNA.
Structural insights into the actions of the PCNA:RNase
HII complex
To gain further insight into our biochemical ﬁndings, we
modeled a nucleic acid substrate bound to the
PCNA:RNase HII complex. Despite differences in
sequence and secondary structure among RNase H
enzymes, catalysis by two metals in the active site is
conserved. Therefore, based on the geometry of the
metal chelating atoms of E. coli RNase HI bound to an
RNA/DNA hybrid (9), the substrate was modeled into
active sites of two Afu RNase HII conformations
(Figure 4). Docking resulted in the 50-end of the RNA
strand positioned proximal to the PCNA ring while the
30-end passes through the substrate-binding region, as pre-
viously deﬁned (7).
In our model, the RNA containing strand of the sub-
strate threads from 50- to 30-through the center of the
PCNA homotrimer to reach the active site and subsequent
binding groove of RNase HII. The orientation of the
binding groove within the context of the complex
suggests that the role of the groove may not be to
enhance substrate binding as was previously thought (8),
but rather to distort the duplex geometry, facilitating
cleavage. This is consistent with the inability of RNase
HII to cleave ribonucleotides within 3 bases of the
Figure 1. Continued
and D150, and RNase HII residues S195 and R198 are labeled. The ﬁnal reﬁned model is shown in simulated annealing omit maps calculated for
models in which residues corresponding to the hinge are removed (B, 3.0s; C, 1.5s; D, 4.0s). (E) Schematic illustrating the range of motion between
the three observed conformations. The hinge point (black sphere) marks the average Ca coordinate of PIP-box residue Q199. Cylinders are coloured
according to the above models and yellow spheres highlight the average Ca coordinate of their respective active site residues. The PCNA ring is
shown for reference (grey semi-transparent surface). (F) Close-up of the hinge region for the two RNase HII chains in which the entire sequence
(195SNLR198) is resolved. These and all other molecular graphics were generated using PyMOL (DeLano Scientiﬁc LLC).
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Figure 2. PCNA enhances RNase HII activity on certain substrates containing single ribonucleotides. (A) Superposition of the three RNase HII
conformations (tan, cyan and red) with the apo RNase HII (grey) crystal structure (PDB ID: 1I39) highlighting the hinge region (residues
195SNLR198) and PIP-box motif (residues 199QKTLDDF205). Active sites residues are in yellow. (B) The RNase HII-PCNA interaction requires
the PIP-box, but not the hinge region: GST-tagged wild-type, hinge deletion mutant (SNLR), or PIP-box deletion mutant (PIP) RNase HII was
bound to glutathione beads and incubated with PCNA. Bound and unbound proteins were separated by SDS-PAGE and Coomassie stained.
(M=Molecular weight marker) (C) Substrates used in panels D–F and G, respectively: 50-labeled oligonucleotides (*) with a single ribonucleotide
were annealed to a complementary DNA 18-mer. RNA bases in lower case (red); DNA bases in uppercase (black); cleavage positions indicated by
arrows. (D) PCNA enhances RNase HII activity: Substrate D14R1D3:D18 was incubated with Afu RNase HII and/or PCNA and separated by
denaturing PAGE. (E) Enhancement of activity was lost when the RNase HII PIP-box was deleted (PIP), (F) or when four hinge residues were
removed (SNLR). (G) PCNA inhibits RNase HII activity on substrate containing a ribonucleotide nearer the 50-end (D5R1D12:D18).
Contaminating nuclease activity in the recombinant proteins was excluded as neither PCNA alone, nor the RNase HII D101N active site mutant
(data not shown) showed any substrate cleavage. All protein concentrations are indicated in nM; all assays were performed with 250 nM of substrate.
Reactions incubated for 20min at 30C, except F (120min).
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30-end of duplexes, even in the presence of PCNA
(Supplementary Figure S2H).
To determine the relative position of the RNase HII
catalytic site along the substrate, the docked hybrid was
extended through the PCNA ring using a model for a
B-form DNA duplex. The depth of the PCNA toroid is
27 A˚, equivalent to eight vertically stacked base pairs.
In the crystal structure, the active sites of the RNase
HII molecules are located 19.6, 46 and 49 A˚ from the
center of the PCNA trimer, corresponding to 6, 13 and
14 base pairs, respectively (Figure 4). For the two
extended conformations the active sites lie within reach
of RNA bases whose cleavage was stimulated by PCNA.
However, for the third ‘closed’ conformation, substrate
could not be modeled due to steric clashes and may
represent an inhibitory state for the non-chromatin
associated complex.
Our modeling shows that the catalytic site of RNase
HII as part of the PCNA:RNase HII complex can
access ribonucleotide bases distal to the 50-end, but is
physically obstructed from accessing those proximal,
providing an explanation for the observed
position-dependent PCNA activation and inhibition of
RNase HII. Also implicit to this model is that PCNA
confers strand speciﬁcity to the action of RNase
HII, with enzymatic activity restricted to the strand
passing 50–30 from the center of the PCNA ring to the
catalytic site of the enzyme. This is supported by our
biochemical data: In the absence of strand speciﬁcity,
embedded ribonucleotides at positions 2–10 would be
accessible to and cleaved by PCNA:RNase HII loaded
from the opposite end, as PCNA rings can slide onto
both ends of double stranded substrate in our in vitro
system (48).
Structure of human PCNA with the RNASEH2B
PIP-box peptide
Human RNase H2 is a complex of three subunits
(RNASEH2A, RNASEH2B and RNASEH2C), all of
which are required for activity. Afu RNase HII shares
29% sequence identity with the catalytic RNASEH2A
subunit. However, it is the RNASEH2B subunit of the
eukaryotic enzyme that contains the PCNA binding site
(26). Therefore, to extend our observations for Afu
PCNA:RNase HII to the corresponding human complex
we solved the structure of a peptide from the C-terminus
of human RNASEH2B bound to human PCNA to 3 A˚
resolution (Table 1, Figure 5A).
Twelve residues (DKSGMKSIDTFF) of the peptide
were resolved in the ﬁnal structure. Similar to Afu, the
human RNASEH2B PIP-box interaction can be
characterized by two distinct features: a 310 helix that
anchors into a hydrophobic pocket and a short stretch
of amino acids N-terminal to the helix that form a
&nbsp;b-sheet with the PCNA C-terminus (Figure 5B).
Superposition of the PCNA components of human and
Afu complexes demonstrates that the PIP-box structural
motif is highly conserved through evolution (Figure 5C).
The amide nitrogen of K6 and the carbonyl oxygen of G4
from the peptide hydrogen bond to the carbonyl oxygen of
PCNA:P253 and the amide nitrogen of PCNA:I255, re-
spectively, forming a b-zipper. This hydrogen-bonding
pattern is conserved across many PCNA complexes
(Supplementary Figure S5).
Recombinant PCNA by itself is not sufﬁcient to stimulate
human RNase H2 activity in vitro
As described above, we have shown enhanced activity for
Afu PCNA:RNase HII; we therefore tested for cleavage of
the same substrates by the human complex. However, we
did not observe any effect of PCNA on recombinant
human RNase H2 activity for any of these substrates
(Supplementary Figure S4 and data not shown) over a
range of reaction conditions. The human RNase H2
complex interacts with PCNA, as evident from gel ﬁltra-
tion (26) and co-immunoprecipitation/co-localization ex-
periments (Figure 6). However, we cannot exclude the
possibility that the in vitro enzyme assay conditions are
suboptimal for PCNA to bind the human enzyme and
stimulate activity. Alternatively, given that our ﬁndings
are consistent with the previously reported absence of
stimulation (26), other factors may additionally regulate
its activity. Regulatory post-translational modiﬁcations
affecting enzyme activity have been demonstrated for
other eukaryotic replication proteins (49). The presence
of two additional subunits (RNASEH2B and
RNASEH2C) in the eukaryotic enzyme also suggests the
potential for further regulatory complexity through inter-
actions with other proteins. Such regulation might be
expected, permitting tight temporal and spatial control
over RNase H2 activity.
Human RNase H2 but not RNase H1 localizes to
replication foci
To conﬁrm the physiological relevance of the human
PCNA:RNase H2 complex, we investigated the inter-
action in a cellular context. We found EGFP-tagged
human RNASEH2B to localize almost exclusively to the
nucleus. Notably, 10–20% of transfected cells had
punctate regions of higher intensity ﬂuorescence within
the nuclei, reminiscent of replication foci (Figure 6A).
To further investigate this, cells were detergent extracted
(Figure 6B), revealing EGFP-RNASEH2B co-localization
Table 2. Kinetic parameters for Afu RNase HII in the absence and
presence of PCNA
Km (mM) kcat (min
1) kcat/Km
(min1mM1)
D14R1D3:DNA18
RNase HII 4.5±2.3a 7.1±3.0 1.6
RNase HII+PCNA 0.39±0.16 3.3±0.78 8.4
RNA18:DNA18
RNase HII 2.4±0.7 5.2±1.5 2.1
RNase HII+PCNA 0.15±0.07 0.96±0.17 6.5
aAverages and standard deviations from four independent
measurements.
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with non-extractable PCNA, which is a marker of sites of
replication (50). EGFP-RNASEH2B was consistently
present at replication foci in early-, mid- and late
S-phase (Figure 6C and D), and its expression did not
perturb cell cycle progression. Co-localization at
replication was also seen for EGFP-RNASEH2C with
PCNA, and RNASEH2B with EdU incorporated into
newly synthesized DNA (Supplementary Figure S6).
Furthermore, RNASEH2B localization at replication
foci could be disrupted by mutations in two phenylalanine
Figure 3. PCNA promotes efﬁcient cleavage of Okazaki-like substrates by RNase HII. (A) Sequences of Okazaki-like fragments used in B–F (RNA
bases in lower case, grey; DNA bases in upper case, black). *R10D13:D40 represents newly primed lagging strand DNA, while D17+*R10D13:D40
corresponds to an unprocessed Okazaki junction. Arrows indicate cleavage sites with the size of the arrow indicating the extent of cleavage in the
presence of PCNA. Each 50-labeled substrate (2.5 nM) was incubated with Afu RNase HII and/or PCNA and separated by denaturing PAGE. (B)
RNase HII generates smaller fragments from an unprocessed Okazaki junction. (C,D) PCNA enhances comprehensive cleavage of the RNA primer
at a fully formed Okazaki junction, but not on primase-primed DNA. (E,F) 30 labelling of R10D13 (0.5 nM) demonstrates that PCNA enhances
cleavage at the junctional ribonucleotide of a fully formed Okazaki junction. All protein concentrations are given in nM. In vitro Afu PCNA
homotrimer formation is inefﬁcient at low concentrations, and consequently high concentrations of PCNA were used to supply sufﬁcient PCNA
trimeric rings for stimulation of RNase HII activity.
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residues of the PIP-box motif (Figure 5B; F300A and
F301A), which are required for the interaction with
PCNA (26) (Figure 6E). Although nuclear localization was
unaltered, EGFP-RNASEH2B (FF>AA) (Figure 6A) no
longer co-localized with PCNA after detergent extraction
(Figure 6B). Therefore, the RNase H2 enzyme is targeted
to replication factories through its PIP-box motif in
the same manner as other replication enzymes (29).
Notably, RNase H1 did not localize to replication foci
at all (Figure 6A and B), so we conclude that in
mammalian cells, RNase H2 is the ribonuclease H
enzyme active at sites of replication.
DISCUSSION
Previous biochemical and genetic studies have suggested
roles for RNase H activity in the removal of misin-
corporated ribonucleotides (23) and in Okazaki fragment
maturation (20–22,51). We establish here that Afu PCNA
enhances RNase HII activity on both these substrates, and
Figure 5. Crystal structure of a human PCNA:RNASEH2B PIP-box peptide complex. (A) A peptide corresponding to the C-terminal 18 residues of
the RNASEH2B subunit (green ribbon) binds to each of the three PCNA monomers (light blue ribbon). (B) A view of the PIP-box interface shows
the C-terminal component of the peptide (sticks, carbon atoms green) anchored into the hydrophobic pocket of PCNA (semi-transparent surface and
light blue ribbon), while the N-terminal region forms hydrogen bonds (black dashes) with the backbone of the PCNA C-terminus. Residues F300 and
F301 of RNASEH2B are labeled. Nitrogen and oxygen atoms in the interface are blue and red, respectively. (C) To compare Ca traces of the human
RNASEH2B peptide (green) and the PIP-box of each of the Afu RNase HII conformations (cyan, tan and red), PCNA components of the Afu (grey
ribbon) and human (light blue ribbon) complexes were superimposed.
Figure 4. Model of RNA/DNA hybrid binding to the PCNA:RNase HII complex. An RNA/DNA hybrid was docked into the active site of Afu
RNase HII, based on conserved metal coordination geometry (see ‘Materials and Methods’ section). The hybrid was extended through the PCNA
ring with B-form DNA duplex. The three panels show molecular surfaces of the three RNase HII conformations (cyan, tan and red) from the same
orientation on a single PCNA ring (grey). In the closed conformation (red), the duplex could not be modelled through the PCNA ring without
signiﬁcant steric clashes. The active site residues are shown in yellow and the binding groove (K143, R46, Q43, G161, S162, G163 and Y164) in blue.
The color of bases along the RNA/DNA hybrid indicate the observed pattern of PCNA stimulation (green) and inhibition (red) on RNase HII
cleavage. Arrows indicate the 50- and 30-ends of the RNA strand.
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that human PCNA localizes RNase H2, but not RNase
H1, at replication foci. Therefore we conclude that type
2 RNase H in complex with PCNA provides the predom-
inant RNaseH activity at sites of genome replication and
repair. Our structural and biochemical data on the Afu
PCNA:RNase HII complex also permit us to reassess
previously proposed models and more clearly deﬁne how
this enzyme acts in DNA replication and repair.
Figure 6. PCNA is sufﬁcient to localize human RNase H2 to replication foci. (A) EGFP-RNASEH2B, the PIP-box mutant EGFP-RNASEH2B
(FF>AA) and RNASEH1-EGFP (without mitochondrial localization signal) (5) localize to the nucleus in non-extracted COS7 cells. (B) Detergent
extracted cells: EGFP-RNASEH2B requires an intact PIP-box to co-localize with PCNA at replication foci. RNASEH1-EGFP does not localize to
replication foci. (C) EGFP-RNASEH2B co-localizes with PCNA through early-, mid- and late S-phase EGFP (green), PCNA (red), DAPI (blue);
scale bars are 10 mm. (D) Quantiﬁcation of co-localization between EGFP-RNASEH2B and PCNA in cells represented in panel B. Categories
represent the percentage of foci with co-localizing signals in a cell. Graph shows average values of three independent experiments (100 cells per
experiment); error bars indicate standard deviations. (E) RNase H2 interacts with PCNA in COS7 cells in a PIP-box dependent manner. EGFP
proteins were afﬁnity puriﬁed using GFP-Trap (Chromotek) from cell lysates. Bound/unbound proteins were detected by Western analysis.
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The role of PCNA:RNase H2 in removal of
misincorporated ribonucleotides
Signiﬁcant numbers of ribonucleotides are misincor-
porated during DNA synthesis by replicative DNA poly-
merases. Indeed, ribonucleotide bases may be present at a
frequency of one in every few thousand base pairs of
newly synthesized DNA. As DNA polymerases have
difﬁculties bypassing these ribonucleotides in template
DNA (24), a surveillance and repair mechanism that
removes such ribonucleotides will be crucial to maintain
genomic stability. Type 2 RNase H has the apparently
unique ability to recognize and cleave single
ribonucleotides embedded in DNA duplexes, making
it a strong candidate for initiating such a process. Our
demonstration that PCNA enhances RNase HII activity
against such substrates suggests that this complex acts in
this type of DNA repair, probably together with FEN1
which removes the ribonucleotide once a nick has been
made (23). We therefore predict that PCNA:RNase H2
scans for misincorporated ribonucleotides in a processive
strand-speciﬁc scanning mode, conferring increased
efﬁciency over 3D diffusion that would be required for
RNase H2 alone (Figure 7A).
PCNA directs type 2 RNase H enzymatic activity
The sequential action of RNase H2 and FEN1 could
simply involve direct competition for the same PCNA
binding site. However, a more interesting possibility is
that they occupy two of the three available binding sites
on the same PCNA trimer. PCNA would then coordinate
their enzymatic activities, permitting substrate hand-off
from one protein to the next. Structural modeling of a
potential FEN1:PCNA:RNase HII complex demonstrates
that this is possible, as the FEN1 and RNase HII hinges
allow simultaneous binding without steric hindrance
(Supplementary Figure S7). A similar coordinated transi-
tion from FEN1 to DNA ligase I has been suggested (52),
and therefore this could represent a general mechanism for
PCNA to facilitate sequential enzyme action.
Conformations observed for other DNA-editing enzymes
bound to a physiological PCNA ring have been suggested
to reﬂect different activation states (45,53,54), but here we
show a direct correlation between enzyme activity and
conformation. Through biochemistry, utilizing ribo-
nucleotides embedded at different substrate positions,
and structural modeling of hybrids in the context of
the complex, we infer that one state represents an
inactive enzyme:PCNA complex, while two other orienta-
tions are enzymatically active forms. Furthermore, our
experiments with embedded ribonucleotides allow us to
demonstrate that PCNA confers strand speciﬁcity to
RNase HII function that indeed may represent a general
property for PCNA in the control of enzyme activities
during replication and repair.
Models for PCNA:RNase H2 function in replication
The existence of multiple redundant pathways to deal with
the discontinuous nature of lagging strand replication is
generally assumed. Genetic studies in Saccharomyces
cerevisiae suggest that RNase H2 acts in parallel with
Rad27 (FEN1), Dna2 and Rad51 pathways in replication
and repair (55,56). Although there is a signiﬁcant case for
a role of RNase H2 in Okazaki fragment processing, its
precise function has remained elusive. Not least because
RNase H2 is not an essential enzyme in S. cerevisiae and
processing mechanisms involving ﬂap generation have
been highlighted in the recent literature (18,30). These
mechanisms involve the displacement by Pol d of a
50–30-ﬂap of a downstream Okazaki fragment containing
the RNA primer. This ﬂap can be removed by the
endonucleolytic activity of FEN1 or DNA2, without any
FEN1
lagging strand
RNA primer
(~10 nt) DNA primer
upstream
Okazaki fragment
D
RNaseH2
PCNA
ppp
C RNaseH2
PCNA
B
ppp
DNA2RPA
ppp
ppp
PCNA
Pol δ
misincorporated 
ribonucleotides
RNaseH2
A PCNA
Figure 7. Models for PCNA:RNase H2 function in DNA repair and
replication. (A) PCNA promotes type 2 RNase H recognition and
cleavage of ribonucleotides that may become misincorporated during
DNA synthesis. (B) Okazaki fragment maturation can occur through
cleavage of 50–30-ﬂaps by FEN1 or DNA2. Cleavage generates single
stranded 50-ppp RNA-DNA chimeras that have the potential to be
highly immunogenic. (C) Fold-backs in raised ﬂaps prevent resolution
of these ﬂaps by FEN1 (57). PCNA:RNase H2 cannot degrade the
RNA primers in such hairpin structures, as PCNA obscures the
primer. (D) PCNA:RNase H2 can efﬁciently remove RNA primers
from Okazaki fragment junctions prior to ﬂap generation by Pol d,
preventing formation of 50-ppp nucleic acids.
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requirement for RNase H activity (Figure 7B). However,
FEN1 cleavage can be blocked if the strand folds back,
forming a hairpin (57). RNase H2 has been proposed to
play a role in processing these hairpin duplexes (58).
However, our data indicate that the PCNA:RNase H2
complex cannot process such structures as the ribonucleo-
tide containing strand must pass 50–30 through PCNA to
reach the active site of RNase H2 (Figure 4). In the
fold-back hairpins, the RNA primer would be masked
by PCNA (Figure 7C).
Our data therefore favor RNase H2 acting on the RNA
primer while it is still annealed to the lagging strand
(Figure 7D). In vitro studies suggest that primer removal
can be effected by RNase H2 cleavage of the primer, with
the remaining ribonucleotide then removed by FEN1.
Here we show that PCNA enhances RNase HII activity
on Okazaki-like substrates in the presence of a completed
upstream Okazaki fragment. PCNA:RNase HII also
promotes more complete hydrolysis of the RNA primer,
allowing ready dissociation of the resulting fragments.
This is likely to be more energetically favorable than dis-
placement of the intact primer by Pol d in the form of a
ﬂap. Established mechanisms (18) that raise 50–30-ﬂaps
result in release of 50-tri-phosphate nucleic acids
(50-pppRNA-DNA, Figure 7B). Unless degraded these
could evoke an innate immune response: 50-ppp nucleic
acid species are potent agonists of intracellular pattern
recognition receptors such as RIG-I (59,60). Primer
degradation by PCNA:RNAse H2 prior to such ﬂap
generation would suppress the production of immuno-
stimulatory 50-ppp nucleic acids.
In summary, our ﬁndings provide important structural
insights into how RNase H2 acts with PCNA to scan for
misincorporated ribonucleotides and also rationalize the
mechanisms by which this enzyme complex could act in
Okazaki fragment processing. This will inform future bio-
logical investigations into the physiological functions of
this enzyme and will be important in deﬁning the nature
and role of nucleic acids in the pathogenesis of systemic
autoimmune disease.
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